Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks buddy....
I hate to be a downer however my poor old dog Rusty got ran over yesterday. As my wife ran around in historics and I was apparently holding my head on my shoulders because I couldn’t remove them from my head as I looked him (and all his insides) looking up at me. I was so sad at that moment.
You wonder what could all this have to do with EAPH?
Well at that moment I thought of EAPHHHHH’s future and how they had a lot in common. Nether Rusty nor EAPH felt a thing. They went quickly and without pain:
Rusty was about 14 and was going blind and deaf. Kinda like EAPHHHHH
Rest In Peace Rusty..... will always love you little man....
GO EAPHHHHH...... can you say .003 for next milestone???
Really? Like i said.. I can’t play that game. Money to be made between .0015 and .0025. But it takes two working together. One buys the other sells and you split the profit.
This is a turd.
Nothing real here except deception and lies.
Good luck to all.
Good trading today. A sign of progress will be a close above .0020 today.
GO EAPHHHHH....
There’s money to be made between .0016 and .0023 but I just can’t play that game.
Good luck to everyone.
It’s the EKG chart again. So predictable.
We need some good news.
GO EAPHHHHH.....
My favorite color.
GO EAPHHHHH......
Priceless
Honesty and integrity is exactly what shows transparency which is something you 007 have no interest in whatsoever.
Up-to-date 0023 back down to 0016 and then right where we started that 002. That’s EKG control in charge if I ever saw it with 1.3 mil traded
And I’m not whining. I’m just keeping it real. Because there are many good Penny land stocks out there to invest in Without giving our hard earned money to companies that just want to steal it.
Thank you.
Finally someone making some sense.
I concur 100 percent.
Creditable news is only thing that will turn this stock around now.
Smoke and mirrors don’t work here anymore.
Your not shaking me.
I’ve rode this mother to zero before.
I’ll do it again...... and again.
Where is the News.
Oh. There isn’t any.
I invest with money.
Peanuts are for monkeys....
You and your stupid ass acronyms that no one understands or want to. ...
Keep hiding behind your facades 007...
Believe me. 007 is far from James Bond. He’s your best friend until you disagree with him. Then he’s you worst enemy.
Where the hell is that New News you talked about 007???
In this case no news is bad news.
But hay.
One guy can simply type BUY BUY BUy. And everyone applauds.
So I’ll just stick with my:
GO EAPHHHH.....
Cross my fingers, click my heels and say “There’s on place like home”.
Because thats about the only logistic associated with this company
See 007?
It freckling don’t matter what we do someone is controlling this stock.
Reminds me of the “Frank and Doggman” show back in the day.
One would buy the other would sell and the two of them could control the chart like an EKG.
And I know what you mean by “everyone doing their part”. But that is so counter productive. It means the company is useless....
Takes a licking and keeps on tickin
GO EAPHHHHH.
Good job today team
Good luck sir. One of our old buddies did that several years ago. He was (sounds like) Mackenzie??? I forgot his handle here. But they turned him away. EAPH IS NOT friendly to stakeholders or the public. He left very angry.
Now you may have better luck.
I look very forward to your report.
Give them a call. If anyone’s from southern Canada go see if they exist anymore.
Easton Pharmaceuticals Inc
Easton Pharmaceuticals, Inc. designs, develops and markets topically delivered therapeutic health care products. The Company's gel formulation delivers non-invasive, naturally-derived treatments for female sexual dysfunction, scar and stretch marks, cellulite and varicose veins.
CURRENT PRICE
EAPH:US0.00USD+-0.00-15.79%
AS OF 03/26/2021
SEE QUOTE
SECTOR
Health Care
INDUSTRY
Health Care
SUB-INDUSTRY
Biotech & Pharma
FOUNDED
07/24/1998
ADDRESS
375 University Avenue Suite 900 Toronto, ON M5G 2J5 Canada
PHONE
1-416-619-0291
WEBSITE
www.eastonpharma.com
NO. OF EMPLOYEES
That you sir. May I have another.
Wow. I’ve been on this site so long I can almost tell what everyone looks like. So many different personalities. I only stick around here because I can’t wait to see what you all have to say next. I honestly only wish the best for everyone here. Have a good day everyone...
I want to be positive 007 but it just don’t make a whole Lotta sense to me
Peanuts? Well that makes me feel better 007 at least I’m not as foolish as some other people out there
That honestly and whatever other buzz words you used 007 needs to the two guys who’s mug shots are on the board.
I’ve got over 13000 invested here and won’t brake even unit it reaches .02.
So I am not just a passer by.
I timed the release of my EAPH 2019 business. Was I the only one that noticed the sell off after the news?
Buyers beware....
Thanks 007.
Here is some business EAPH was working back in 2019..
Easton Pharmaceuticals Turns to Profit in Q1, Provides Business Update
GlobeNewswireJun. 13, 2019 8:30 AM ETEaston Pharmaceuticals Inc. (EAPH)
TORONTO, June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Easton Pharmaceuticals Inc. (EAPH) (OTC: EAPH) (“Easton” or “the Company”) announces it has filed its quarterly report for the three months ended March 31, 2019, and provides several key updates on its business initiatives.
Q1 Filing
In the first quarter of 2019, Easton Pharmaceuticals recorded revenues of $612,689 and turned from a loss to post net income of $7,878. Revenues were generated from the Company’s contract with a prominent developer to frame 150 new homes in Whitby, Ontario, Canada, under its newly created real estate development division. This is the first of several revenue-generating contracts underway, demonstrating the Company’s continued efforts to build a solid foundation and add shareholder value.
Business Update
As part of its broader growth strategy, Easton Pharmaceuticals has created four new divisions while maintaining its pharmaceutical division and distribution agreement with Bayer.
The new real estate development division will manage ownership of the Company’s properties in Georgina, Ontario, and Cobourg, Ontario. Easton Pharmaceuticals is considering additional usage options for the Georgina property that are currently permitted under its zoning, such as self-storage units or a possible residential development. Meanwhile, the Company is preparing to submit a new site plan application for its proposed residential development of multiple units on the Cobourg property, with projected profits to exceed $30 million over the next three years.
The real estate division will also provide construction services to builders and other clients. The aforenoted revenue-generating contract is ongoing, with expectations that more homes will be added and the contract extended.
Easton’s recently created gaming division is expected to launch its games in a casino in the United States by Q3 2019. The Company also recently completed its acquisition of Supreme Sweets, a food processing company in Toronto, Ontario, which marks Easton’s entry into the food and beverage industry and the creation of its food and beverage division. Easton has taken over the management of Supreme Sweets and is continuing to sell products to its DSD (direct sales delivery), co-packing and corporate clients. Supreme Sweets has recently hired two seasoned sales professionals and has also engaged an agency to rebrand the company and its products.
Easton Pharmaceuticals has additionally formed a cannabis division and is in discussions with several licensed producers of medicinal marijuana in Canada to potentially complete a strategic partnership for the launch of its cannabis-infused edibles.
About Easton Pharmaceuticals Inc.
Easton Pharmaceuticals is a diversified specialty pharmaceutical company with a strategic growth plan. The Company recently acquired a food processing company with the intent of growing the traditional business while entering the cannabis-infused edibles market. It has also added real estate development, food and beverage, gaming and cannabis divisions to extend its marketability.
Easton Pharmaceuticals previously developed and owned an FDA-approved wound-healing medical drug and currently owns topically delivered drugs to treat cancer and other therapeutic products in various stages of development and approval. Easton, together with BMV Medica S.A., owns the exclusive distribution rights in Mexico and Latin America for two patented women's diagnostic products and a novel natural treatment for bacterial vaginosis, which they have sub-licensed to Bayer and Gedeon Richter (GEDRF). For more information, visit www.EastonPharmaceuticalsInc.com.
Safe Harbor
This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when certain words or phrases such as "hope", "positive", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
Contact Information
Easton Pharmaceuticals Inc.
www.EastonPharmaceuticalsInc.com
Tel: 647.362.5700
Email: EastonPharma@protonmail.com
Source: Easton Pharmaceuticals Inc. 2019 GlobeNewswire, Inc.
As you can see. Fell to around .007 then back up to .0019. Same old same old.
Typical cal pump and dump. But this one was a dump and pump....
This is a rinse and repeat.
Well hell yes you are if you bought .0007 and sold early last week.
Those of us stuck in the seller must try to wait it out and hope that EAPH can pull something positive and true. That would go a long way toward increased revenue and trustability
If this is truly a scam how could EAPH survive to even be in business.
I don’t know. I guess I’m hopelessly frustrated.
Feel kind of foolish for investing here in the first place.
3.5 mil. Sold on Friday at were at .0018.
Oh well...
Give us some new news.
GO EAPHHHHH...
Triple witching... 19th.
Thanks 007.
By the way. In your honest opinion do think that EAPH has a chance to strike another deal with Bayer?
I has a folder with all those articals. I'm still looking for those links. I'll share if I find them.
My guess though would be that those links were taken down.
I'm sure 007 has them but he's the type that wants to use "DD" instead of sharing.
I really do think EAPH was in the running for this contract. In the early posts they showed docs but then stopped.
Oh yes. Dont forget it was to take place in South America
007 also knows that it dealt with Bayer, EAPH. Monistat and female virginal infection.
Great story. Bayer's logo was on EAPH's old website.
Was never proven to be legitimate.
Would be nice if this new ruling somehow directly affects a lagitamate contract between EAPH and Bayer